NCT04806854View on ClinicalTrials.gov

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

April 30, 2030

Study Completion Date

July 31, 2030

Conditions
Growth Hormone Deficiency
Interventions
DRUG

LUM-201

Administered orally once daily

Trial Locations (1)

Unknown

Institute of Maternal and Child Research, University of Chile, Santiago

Sponsors

Lead Sponsor

Lumos Pharma
All Listed Sponsors
lead

Lumos Pharma

INDUSTRY